Tanvi Patel

Individual investor, main focus biotech. Tweets are ideas not recommendations.

[Tanvi Patel @catalystinvstor]

@MajorGainz7 comparator cohorts reported.
Conclusion: This interim RWE analysis did not demonstrate increased incident lung cancer proportions in TI users versus multiple other T2D cohorts. $MNKD 3/3

[Tanvi Patel @catalystinvstor]

@MajorGainz7 occurred (0.49%). In the RAA cohort, incidence was 1.17%, of 8,936 users. Incidence in the other comparators was: no therapy 1.12%, non-insulin 0.68%, oral agents 0.81%, GLP-1 0.33%, and long-acting insulin 0.78%. Mean time at risk in TI was 1,941.9 days, longer than all…2.1/3

[Tanvi Patel @catalystinvstor]

Great news for kids. U.S. Food and Drug Administration (FDA) has approved Afrezza® (insulin human) Inhalation Powder for use in children and adolescents aged 6 and older living with type 1 and type 2 diabetes #Needlefreeinsulin
#Diabetes #T1D #Type1Diabetes #T2D #WeAreNotWaiting

[Tanvi Patel @catalystinvstor]

$MNKD

[MannKind @MannKindCorp]

MannKind is excited to announce that the U.S. Food and Drug Administration (FDA) has approved the first needle-free treatment option for pediatric patients living with type 1 diabetes. Learn more in the Company Announcement here: https://t.co/x0TFQg3HDw

Important Safety Information: https://t.co/x0TFQg3HDw
Prescribing Information: https://t.co/2FZtyJna2E
#Press #FDA #Diabetes #T1D

[Tanvi Patel @catalystinvstor]

@realandybamberg Agreed with you on that point.

[Tanvi Patel @catalystinvstor]

Eli Lilly's $LLY dealmaking spree just keeps going, but this time, company is returning to a category it's been absent from for years: vaccines & infectious diseases. $ABUS fits in this category well & they have positioned the company for sale. Hepatitis B & mRNA delivery technol

[Tanvi Patel @catalystinvstor]

Bodes well for $ABUS as it owns (w/h Genevant) the delivery technology used for mRNA vaccines. If $LLY buy abus, would $PFE make a counter offer as they have to pay for Abus’s intellectual property PFE used for COVID vaccines anyway https://t.co/T411kUiQrm https://t.co/T411kUiQrm

[Tanvi Patel @catalystinvstor]

Correction, misinformation happened after UTHR Q4 earnings call and $UTHR Q1 2026 conference call (May 6, 2026) was a total narrative shift from the "stealth competition" fears of February. It served as a massive "correction" to the misinformation that previously tanked $MNKD.

[Tanvi Patel @catalystinvstor]

$MNKD finally reclaiming what was lost! 🚀 Wrongly punished and manipulated down 55% on $UTHR Q2 misinformation—today's Q3 call set the record straight. Up 40%, but just getting started.

[Tanvi Patel @catalystinvstor]

@TheMightyForego I see it as a vote of confidence in $ABUS as an investment. Happy to see that they have recognized the value.

[Boudin @boudin420]

Tutes are buying $MNKD dip ahead of PDUFA ...

[BiotechTV @BiotechTV]

𝐁𝐚𝐫𝐜𝐥𝐚𝐲𝐬 𝐌𝐢𝐚𝐦𝐢: In addition to being CEO of @MannKindCorp, Michael Castagna is a diabetic who uses his company's own product (Afrezza inhaled insulin). He demonstrated how it works. $MNKD

[Tanvi Patel @catalystinvstor]

$MNKD https://t.co/tyqlnlsV2w

[Tanvi Patel @catalystinvstor]

This confirms what some of us already knew that $Abus was the real inventor of this technology and Moderna $MRNA obtained it through back door, used it and lied about using someone else’s invention as their own for so long.

[Tanvi Patel @catalystinvstor]

Arbutus secured legal leverage: $ABUS patents and LNP delivery platform are validated.

Judgment of Infringement: Moderna $MRNA has consented to a court judgment of infringement and no invalidity for the four key patents at the center of the case.

[Tanvi Patel @catalystinvstor]

Arbutus secured legal leverage: $ABUS patents and LNP delivery platform are validated.

Judgment of Infringement: Moderna $MRNA has consented to a court judgment of infringement and no invalidity for the four key patents at the center of the case.

[Phoenix Biotech @BiotechAnalysst]

$MNKD earnings tomorrow
$UTHR announcement

[Tanvi Patel @catalystinvstor]

$MNKD

[Tanvi Patel @catalystinvstor]

@RNAiAnalyst Almost imminent. March 9 is the date jury trial starts.